Lexington, MA, United States of America

Thomas Saltmarsh Rush, Iii

This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignee: Wyeth. Active years: 2007-2011.

USPTO Granted Patents = 5 

Average Co-Inventor Count = 9.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2007-2011

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Thomas Saltmarsh Rush, III: Innovator in Biaryl Sulfonamides

Introduction

Thomas Saltmarsh Rush, III is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of biaryl sulfonamides. With a total of 5 patents to his name, Rush has established himself as a key figure in his area of expertise.

Latest Patents

Among his latest patents is one titled "Biaryl sulfonamides and methods for using same." This invention relates to biaryl sulfonamides and their application as metalloproteinase inhibitors. Another significant patent is focused on "Aggrecanase structure," which pertains to aggrecanase polypeptides, their complexes, and related methods and software systems. These innovations highlight Rush's commitment to advancing scientific knowledge and practical applications in biochemistry.

Career Highlights

Thomas Rush is currently associated with Wyeth, a prominent company in the pharmaceutical industry. His work at Wyeth has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to innovative research.

Collaborations

Some of his notable coworkers include Phaik-Eng Sum and Steve Yikkai Tam. Their collaborative efforts have likely played a role in the successful development of Rush's patents and innovations.

Conclusion

Thomas Saltmarsh Rush, III is a distinguished inventor whose work in biaryl sulfonamides and aggrecanase structures has made a significant impact in the field of biochemistry. His contributions continue to influence research and development in the pharmaceutical industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…